Follow
Stefan Prekovic
Stefan Prekovic
Center for Molecular Medicine, UMC Utrecht
Verified email at umcutrecht.nl - Homepage
Title
Cited by
Cited by
Year
Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis
MD Wellenstein, SB Coffelt, DEM Duits, MH van Miltenburg, M Slagter, ...
Nature 572 (7770), 538-542, 2019
3952019
Structure of the homodimeric androgen receptor ligand-binding domain
M Nadal, S Prekovic, N Gallastegui, C Helsen, M Abella, K Zielinska, ...
Nature communications 8 (1), 14388, 2017
1742017
Androgen receptor antagonists for prostate cancer therapy
C Helsen, T Van den Broeck, A Voet, S Prekovic, H Van Poppel, S Joniau, ...
Endocrine-related cancer 21 (4), T105-T118, 2014
1642014
Emerging mechanisms of enzalutamide resistance in prostate cancer
F Claessens, C Helsen, S Prekovic, T Van den Broeck, L Spans, ...
Nature reviews urology 11 (12), 712-716, 2014
1432014
The effect of F877L and T878A mutations on androgen receptor response to enzalutamide
S Prekovic, ME van Royen, ARD Voet, B Geverts, R Houtman, D Melchers, ...
Molecular cancer therapeutics 15 (7), 1702-1712, 2016
1072016
The role of single nucleotide polymorphisms in predicting prostate cancer risk and therapeutic decision making
T Van den Broeck, S Joniau, L Clinckemalie, C Helsen, S Prekovic, ...
BioMed research international 2014, 2014
732014
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ...
Nature communications 12 (1), 5307, 2021
692021
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
S Linder, HG van der Poel, AM Bergman, W Zwart, S Prekovic
Endocrine-related cancer 26 (1), R31-R52, 2019
652019
Drivers of AR indifferent anti-androgen resistance in prostate cancer cells
F Handle, S Prekovic, C Helsen, T Van den Broeck, E Smeets, L Moris, ...
Scientific reports 9 (1), 13786, 2019
562019
Comparative genomic and transcriptomic analyses of LNCaP and C4-2B prostate cancer cell lines
L Spans, C Helsen, L Clinckemalie, T Van den Broeck, S Prekovic, ...
PloS one 9 (2), e90002, 2014
542014
Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1
L Spans, T Van den Broeck, E Smeets, S Prekovic, B Thienpont, ...
Oncotarget 7 (17), 24326, 2016
392016
Glucocorticoid receptor triggers a reversible drug-tolerant dormancy state with acquired therapeutic vulnerabilities in lung cancer
S Prekovic, K Schuurman, I Mayayo-Peralta, AG Manjón, M Buijs, S Yavuz, ...
Nature Communications 12 (1), 4360, 2021
382021
Identification of mineralocorticoid receptor target genes in the mouse hippocampus
LTCM van Weert, JC Buurstede, HCM Sips, S Vettorazzi, IM Mol, ...
Journal of neuroendocrinology 31 (8), e12735, 2019
352019
Duality of glucocorticoid action in cancer: tumor-suppressor or oncogene?
I Mayayo-Peralta, W Zwart, S Prekovic
Endocrine-related cancer 28 (6), R157-R171, 2021
342021
Molecular underpinnings of enzalutamide resistance
S Prekovic, T Van den Broeck, S Linder, ME van Royen, AB Houtsmuller, ...
Endocrine-related cancer 25 (11), R545-R557, 2018
342018
TLE3 loss confers AR inhibitor resistance by facilitating GR-mediated human prostate cancer cell growth
SAL Palit, D Vis, S Stelloo, C Lieftink, S Prekovic, E Bekers, I Hofland, ...
Elife 8, e47430, 2019
282019
Androgen and glucocorticoid receptor direct distinct transcriptional programs by receptor-specific and shared DNA binding sites
M Kulik, M Bothe, G Kibar, A Fuchs, S Schöne, S Prekovic, ...
Nucleic acids research 49 (7), 3856-3875, 2021
262021
The androgen receptor depends on ligand‐binding domain dimerization for transcriptional activation
S El Kharraz, V Dubois, ME van Royen, AB Houtsmuller, E Pavlova, ...
EMBO reports 22 (12), e52764, 2021
252021
Endonuclease FEN1 Coregulates ERα activity and provides a novel drug Interface in Tamoxifen-resistant breast Cancer
KD Flach, M Periyasamy, A Jadhav, D Dorjsuren, JC Siefert, TE Hickey, ...
Cancer research 80 (10), 1914-1926, 2020
232020
A CRISPR-Cas9 screen identifies essential CTCF anchor sites for estrogen receptor-driven breast cancer cell proliferation
G Korkmaz, Z Manber, R Lopes, S Prekovic, K Schuurman, Y Kim, ...
Nucleic Acids Research 47 (18), 9557-9572, 2019
222019
The system can't perform the operation now. Try again later.
Articles 1–20